|
This document is a submission to the TSCA 8(e)/FYI database detailing various studies, including a status report by the C8 Science Panel on the association of PFOA and PFOS with uric acid levels among adults exposed to PFOA in the Mid-Ohio Valley.
|
2009 |
AR226-3884
|
jgarooxLbLBYr1bNZQKG1meoZ |
55 |
|
The document is a submission to the TSCA 8(e)/FYI database regarding PFOA and PFOS, including two studies: one on the health outcomes of PFOA production workers over 30 years, which found no clinical evidence of disease despite varying serum PFOA levels, and another investigating the impact of perfluoroalkyl compounds on human semen quality.
|
2009 |
AR226-3887
|
xjKD01v4GMLYrzBp7pGJ70zjy |
37 |
|
3M submitted a TSCA 8(e) Substantial Risk Notice to the EPA, providing supplemental data on the detection of various fluorochemicals, including PFOS and PFBA, in fish tissues from a validation study, while asserting that these findings do not meet the substantial risk reporting threshold.
|
2009 |
AR226-3889
|
RabeMamRmK1eKz1b1MNDOodY8 |
45 |
|
This document is a submission to the TSCA 8(e)/FYI database by Taft Stettinius & Hollister LLP, providing multiple reports and information regarding PFOA and PFOS, including studies on serum concentrations and pregnancy outcomes related to PFOA exposure in communities near chemical plants.
|
2009 |
AR226-3890
|
6w4mONQvg7njq7E7XxnQ38Zp1 |
89 |
|
The document is a submission to the TSCA 8(e)/FYI database regarding PFOA/PFOS, including multiple reports and studies from the C-8 Science Panel on PFOA serum concentrations and pregnancy outcomes related to community exposure, as well as a letter from ATSDR on drinking water recommendations.
|
2009 |
AR226-3891
|
YDpZVJk7OVeJZr27bMxn51z0n |
87 |
|
3M submitted a TSCA 8(e) Substantial Risk Notice to the EPA, providing supplemental data on PFOS levels found in fish tissues from the Mississippi River, with concentrations ranging from 28.5 to 382 ng/g, while also noting the presence of other perfluorinated compounds.
|
2009 |
AR226-3892
|
xzpQw2z5rjR8e3RE7q87Zr63E |
32 |
|
This document is a letter from Deborah McCrea of Taft Stettinius & Hollister LLP to the EPA Docket Center regarding the submission of information to the IRIS and AR-226 database for PFOA/PFOS.
|
2009 |
AR226-3893
|
8J6KaozadwpRNvvdxv07ZKVK |
53 |
|
This document is a letter from Taft Stettinius & Hollister LLP to the EPA Docket Center regarding the submission of information related to PFOA/PFOS for the IRIS and AR-226 databases.
|
2009 |
AR226-3895
|
yVEp9zOYvjGm1LmJyKLza23X |
10 |
|
3M submitted a TSCA 8(e) Substantial Risk Notice to the EPA, providing draft biomonitoring data that indicates detectable levels of sulfonate-based and carboxylic-based fluorochemicals, including PFOA and PFOS, in the blood of residents in Washington County, Minnesota, due to exposure from drinking water.
|
2009 |
AR226-3897
|
EvZVv3Y44wjzDd5rbGw2ekwab |
1 |
|
This document is a submission to the TSCA 8(e)/FYI database regarding the detection of perfluorooctanoic acid (PFOA) in New Jersey public drinking water systems, highlighting its occurrence and potential significance as reported in a study by Post et al. (2009).
|
2009 |
AR226-3898
|
a10mz9d63ZVp30m55x6kodv1y |
9 |
|
The document is a submission to the EPA regarding the inclusion of additional information on perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in the Integrated Risk Information System (IRIS) and the AR-226 database, including a final report from a peer consultation panel and a link to a draft toxicological profile.
|
2009 |
AR226-3894
|
EqkMVr7daxB74wKB54Z8wVy44 |
94 |
|
This document is a submission to the TSCA 8(e)/FYI Database regarding the detection of perfluorooctanoic acid (PFOA) in New Jersey public drinking water systems, highlighting its occurrence and potential significance as reported in a study by Post et al. (2009).
|
2009 |
AR226-3899
|
99eqEjmxK7DOO7NwoQVJ7aze3 |
10 |
|
This document is a letter from Taft Stettinius & Hollister LLP to the EPA Docket Center, submitting information related to PFOA/PFOS for inclusion in the IRIS and AR-226 databases.
|
2009 |
AR226-3896
|
8VYDwVbq0VqxB80x0kMO01QZm |
54 |
|
The document is a submission to the TSCA 8(e)/FYI database providing information on studies related to PFOA and PFOS, including research on the disposition of PFOA in mice and its effects on breastfeeding women and developmental exposure.
|
2009 |
AR226-3900
|
e3yv5ebYnD22oaB41RB03RLm |
53 |
|
This document is a submission to the TSCA 8(e)/FYI database regarding studies on PFOA, including analyses of its disposition in tissues of dosed CD-1 mice and its presence in the serum and milk of breastfeeding women.
|
2009 |
AR226-3901
|
KR2mrQwx4DJ3zX00ygEmqbEmX |
52 |
|
This document is a submission to the TSCA 8(e)/FYI database by Taft Stettinius & Hollister LLP, providing information on studies related to PFOA, including research on predictors of PFOA levels in a community surrounding a chemical plant and the C8 Health Project.
|
2009 |
AR226-3902
|
VGQ0QO47bGkVVLdKe8XNE54zN |
63 |
|
This document is a submission to the TSCA 8(e)/FYI database regarding PFOA/PFOS, including references to studies on predictors of PFOA levels in a community near a chemical plant and the design of the C8 Health Project.
|
2009 |
AR226-3903
|
mqjmM0EJGDD0v8YR8d0E6OnQQ |
54 |
|
This document is a letter from Taft Stettinius & Hollister LLP to the EPA Docket Center, submitting information related to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) for consideration in the Integrated Risk Information System (IRIS) database.
|
2009 |
AR226-3904
|
xYXGrv8g7dnMQzQdMaY42K61 |
103 |
|
3M submitted a TSCA 8(e) Substantial Risk Notice to the EPA, reporting detectable levels of sulfonate-based and carboxylic-based fluorochemicals in blood samples from nestling bald eagles in the Mississippi and St. Croix River Valleys, generated as part of a study for the National Park Service.
|
2009 |
AR226-3908
|
BR3GRdO1KeX2G9vLwypnpjn7w |
1 |
|
3M submitted a TSCA 8(e) Substantial Risk Notice to the EPA, providing supplemental information about biomonitoring data that detected levels of sulfonate-based and carboxylic-based fluorochemicals in the blood of residents in Washington County, Minnesota.
|
2009 |
AR226-3906
|
omBqyBJdBDY6Q9GE9eVbxDdRw |
120 |
|
This document is a letter from Taft Stettinius & Hollister LLP to the EPA Docket Center, submitting information related to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) for consideration in the Integrated Risk Information System (IRIS) database.
|
2009 |
AR226-3907
|
ZBo2d1aMoK87qv0JqJbk2pj1J |
12 |
|
This document is a letter from Taft Stettinius & Hollister LLP to the EPA Docket Center regarding the submission of information to the IRIS and AR-226 databases for PFOA/PFOS in response to a previous EPA notice.
|
2009 |
AR226-3912
|
OzYQmo0moXrRvR4K4yYM4qge1 |
23 |
|
The document is a submission to the TSCA 8(e)/FYI database by Taft Stettinius & Hollister LLP regarding the Minnesota Department of Health's "East Metro Perfluorochemical Biomonitoring Pilot Project," which focuses on PFOA/PFOS.
|
2009 |
AR226-3909
|
7M048JbgbdZwDQeX9LJJbxrda |
102 |
|
This document is a letter from Taft Stettinius & Hollister LLP to the EPA Docket Center regarding the submission of information to the IRIS and AR-226 databases for PFOA/PFOS in response to a previous EPA notice.
|
2009 |
AR226-3911
|
wgebx6V798n4OOp9Dw6Vjd76o |
34 |
|
The document is a submission to the TSCA 8(e)/FYI database regarding PFOA/PFOS, specifically referencing the "East Metro Perfluorochemical Biomonitoring Pilot Project" conducted by the Minnesota Department of Health on July 21, 2009.
|
2009 |
AR226-3910
|
QgDJxzg04vjdyRmr8x8Q2kqJk |
91 |
|
This document is a letter from Deborah McCrea of Taft Stettinius & Hollister LLP to the EPA Docket Center, submitting information related to PFOA/PFOS for inclusion in the IRIS and AR-226 databases.
|
2009 |
AR226-3914
|
xjMM5xdZge1nYEYg6gODGYoQG |
8 |
|
This document is a letter from Taft Stettinius & Hollister LLP to the EPA Docket Center regarding the submission of information to the IRIS and AR-226 databases for PFOA/PFOS in response to a notice issued by the EPA.
|
2009 |
AR226-3913
|
pByjg5n4J9aQ03YN3mrqm7Xo7 |
59 |
|
This document is a letter from Taft Stettinius & Hollister LLP to the EPA Docket Center, submitting information related to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in response to a notice issued by the EPA regarding their evaluation.
|
2009 |
AR226-3915
|
mqKa54vKNekVwxb4JXr6KxveZ |
42 |
|
The document is a letter from Taft Stettinius & Hollister LLP to the EPA Docket Center regarding the submission of information to the IRIS and AR-226 databases for PFOA/PFOS in response to a previous EPA notice.
|
2009 |
AR226-3916
|
3JD1JgYx3e62Y8NwoewXEgqp0 |
11 |
|
The document announces that the ILSI Research Foundation is seeking nominations for a Peer Consultation Panel to evaluate data related to the Fluorotelomer-Based Product Biodegradation Testing Supplemental Environmental Project undertaken by E.I. DuPont de Nemours and Company in connection with an enforcement action by the EPA.
|
2009 |
AR226-3917
|
0LLaB2aReJvxYkzNO5ajndN4d |
2 |
|
The document outlines the ILSI Research Foundation's role in administering a Peer Consultation Panel for the Fluorotelomer-Based Product Biodegradation Testing Supplemental Environmental Project, which E.I. DuPont de Nemours and Company is conducting under a Consent Agreement with the EPA, and seeks nominations for panel members to review data related to biodegradation studies.
|
2009 |
AR226-3918
|
ErmG6vYQMQjjo7nL44NR1XL |
1 |
|
This document is a submission to the EPA's Integrated Risk Information System (IRIS) regarding perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), responding to a notice issued by the EPA on February 23, 2006.
|
2009 |
AR226-3919
|
OEQQ3EK1jG9zv2dkd09RqxyM |
7 |
|
This document is a correspondence from Deborah McCrea of Taft Stettinius & Hollister LLP to the EPA Docket Center, including references to multiple letters and comments regarding the draft Toxicological Profile for perfluoroalkyls, indicating ongoing discussions about the health impacts of these substances.
|
2009 |
AR226-3921
|
ByLjLzy6VNN6QojVy6jMV3Dbj |
198 |
|
3M submitted a TSCA 8(e) Substantial Risk Notice to the EPA, providing analytical results for PFOA and PFOS in fish from Alabama surface waters, supplementing previous submissions related to fluorochemicals.
|
2009 |
AR226-3930
|
3ee9a0YyxwkzZrMm7pDeZRQvx |
2 |
|
3M submitted a TSCA 8(e) Substantial Risk Notice to the EPA regarding the results of 2009 analyses of fish from the Mississippi River, specifically detailing findings related to PFOS and other fluorochemicals based on data generated by the Minnesota Pollution Control Agency.
|
2009 |
AR226-3928
|
by4ZrJOgbR4jyRRMJNLKKjKZ1 |
106 |
|
3M submitted a TSCA 8(e) Substantial Risk Notice to the EPA detailing results from a 2009 study on sulfonate-based and carboxylic-based fluorochemicals, including fish and surface water analyses from the Mississippi River, conducted by the Minnesota Pollution Control Agency and the Minnesota Department of Natural Resources.
|
2009 |
AR226-3936
|
v6pO2zEV0KYJRaxwQzQXV1j7Y |
157 |
|
This document is a submission to the TSCA 8(e)/FYI database regarding PFOA/PFOS, including results from the West Virginia University C-8 Health Project and a study on the association between serum perfluoroalkyl chemicals and metabolic syndrome.
|
2009 |
AR226-3872
|
pmwOjxOxNJxagBrRZgv1X4GV6 |
1 |
|
This document is a letter from DuPont to the EPA reporting updated occupational serum sampling results for PFOA from workers at their Circleville, Ohio facility, indicating that the levels of PFOA are generally consistent with previously reported levels.
|
2009 |
AR226-3875
|
NeDaa5145x40pkZgkJa7w7nRE |
2 |
|
This document is a correction letter from DuPont regarding updated occupational serum sample results for PFOA from their Changshu Facility in China, addressing inaccuracies in previously reported data.
|
2009 |
AR226-3876
|
K60Kkw7dKvv7E2opJ5np9jpqN |
7 |
|
This document reports on serum PFOA monitoring results from samples collected by DuPont in November 2008, detailing the average, median, minimum, and maximum concentrations of PFOA across different sample groups analyzed by Axys Laboratory.
|
2009 |
AR226-3877
|
RjmKbmLa37N29ev9KJqQeZ7nv |
5 |
|
This document is a letter from DuPont to the EPA providing updated occupational serum sample results for PFOA from workers at the Villers Saint Paul, France facility, indicating that the levels reported for 2008 are generally consistent with previous findings in an occupational setting.
|
2009 |
AR226-3878
|
ykYXm5DV3LvjYvk5DmXQxwRKX |
2 |
|
The document discusses the associations between serum PFOA (C8) levels and various clinical laboratory values, indicating that while some relationships are strong and interesting, further research is needed to establish any causal links.
|
2009 |
AR226-3873
|
XOJ6ZM5YZREVkDk2kQed2GzNw |
81 |
|
The document is a submission to the TSCA 8(e)/FYI database regarding a status report by the C8 Science Panel that summarizes the relationship between PFOA exposure and immune biomarkers in adults from the mid Ohio valley.
|
2009 |
AR226-3882
|
0Lybzk6G8qQELYYo8oKqk6Q2R |
6 |
|
The document is a submission to the TSCA 8(e)/FYI database regarding PFOA/PFOS, specifically providing updated tabular results from the West Virginia University C-8 Health Project that summarize clinical lab values stratified by age and gender for a population exposed to PFOA.
|
2009 |
AR226-3879
|
ZnYj0pNoYmveQeDaNya2R81q0 |
41 |
|
This document is a status report from the C8 Science Panel summarizing the relationship between PFOA exposure from drinking water and immune biomarkers in adults in the mid Ohio Valley, highlighting the need for further understanding of PFOA's effects on human immune status.
|
2009 |
AR226-3886
|
mqQMGEEkqKM301bqyQXwB0wLd |
5 |
|
This document is a submission to the TSCA 8(e)/FYI database providing information on PFOA and PFOS, including a status report from the C8 Science Panel linking these substances to elevated uric acid levels among adults exposed to PFOA in the Mid-Ohio Valley.
|
2009 |
AR226-3880
|
wrqkekZDYjDxZyqqQxNR3Y8po |
52 |
|
This document is a submission to the TSCA 8(e)/FYI database regarding PFOA/PFOS, including a study on the health outcomes of workers at a PFOA production plant over 30 years, which found no clinical evidence of specific diseases despite varying serum PFOA levels.
|
2009 |
AR226-3881
|
LoXGaakN5k4gJJLddDBnLyzjQ |
37 |
|
The document is a submission to the TSCA 8(e)/FYI Database regarding PFOA/PFOS, including updated tabular results from the West Virginia University C-8 Health Project that summarize clinical lab values stratified by age and gender.
|
2009 |
AR226-3885
|
XR56LDe4Z83DZBQYVV2kRoOmR |
41 |
|
This document is a submission to the EPA regarding a presentation on plasma levels of perfluorocarboxylates, including PFOA and PFOS, from blood donors, indicating a decline in PFOA and PFOS levels from 2000 to 2006, while noting increases in other perfluorinated compounds.
|
2008 |
AR226-3889
|
BrYx5m2Gr3zg1mgJ0kG2ZyNk |
35 |
|
DuPont submitted a final study report on a two-year aerobic soil biodegradation research study for perfluorinated compounds to the EPA, indicating their intention to publish the findings and discuss the results with EPA representatives.
|
2008 |
AR226-3924
|
qdkDmZzKjOoXk47ajZVXbed7K |
299 |
|
The document is a correspondence from Taft Stettinius & Hollister LLP confirming the non-confidential status of documents related to PFOA, specifically addressing the withdrawal of confidentiality claims by DuPont regarding exhibits from a deposition of Michael McCabe.
|
2008 |
AR226-3926
|
93nD4qVyZVj2e9eD3qmpmLwK7 |
404 |
|
3M submitted additional data on perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), and related compounds to the EPA, including several studies on their effects and a correction regarding a previously misidentified test substance.
|
2008 |
AR226-3802
|
5kNBNvdVOYbL38708vr1RMRYN |
2 |
|
This document is a correspondence from Taft Stettinius & Hollister LLP to the EPA, FDA, and CPSC regarding the inclusion of various DuPont documents in the administrative record related to PFOA emissions from Teflon-coated cookware, challenging DuPont's claims of no PFOA release.
|
2008 |
AR226-3805
|
v1XQm4b7LOYOrVvNjjZ86n708 |
2 |
|
The document is a correspondence from Taft Stettinius & Hollister LLP to the EPA, providing information on PFOA blood levels detected in individuals from Ohio and West Virginia due to drinking water contamination, as part of a health project following a class action lawsuit against DuPont.
|
2008 |
AR226-3811
|
GK827me7v325p2g7OBr1Ozx67 |
2 |
|
The document presents summary results of plasma concentrations of C8 (PFOA) and C8 Sulfonate among participants in the C8 Health Project, highlighting demographic stratification and noting that these findings contribute to existing knowledge on perfluorinated compounds.
|
2008 |
AR226-3812
|
DvwoLz90VqDq40Z4eNzL8BvNo |
13 |
|
3M submitted a supplemental TSCA 8(e) notice to the EPA regarding a completed developmental neurotoxicity and thyroid function study on potassium perfluorooctane sulfonate (PFOS), indicating that while the data did not meet the substantial risk threshold, it was provided for inclusion in the 8(e) docket due to ongoing assessments of fluorochemicals.
|
2008 |
AR226-3814
|
qmz88x4w8vDzMmL5qNzy7DoRR |
1 |
|
3M submitted a TSCA 8(e) Substantial Risk Notice to the EPA, providing supplemental data from environmental assessments at its Decatur, Alabama facility, which includes analytical reports on PFOA, PFBS, PFHS, and PFOS from groundwater monitoring wells and sediments.
|
2008 |
AR226-3813
|
mmG9GMakrXJdBqq8g3QgNmM4J |
2 |
|
The document summarizes various studies and reports related to the toxicological and environmental properties of Perfluorobutyrate (PFBA), including human biomonitoring data from 3M employees and residents of Washington County, revealing that only 5% of tested individuals had detectable levels of PFBA in their serum.
|
2008 |
AR226-3815
|
7O5z4MZJLg1G9ZmY5rQ5VV47B |
6 |
|
The document provides updated occupational serum sampling results for PFOA levels among workers at the DuPont Chambers Works site in New Jersey for December 2007, indicating levels that generally corroborate previous findings in an occupational setting.
|
2008 |
AR226-3816
|
91m2v7qBw2LzyG5Z8G997BKyD |
12 |
|
This letter from DuPont reports the results of two 28-day feeding studies in rats evaluating the effects of a test substance, likely PFOA or a related perfluorinated compound, revealing significant adverse health impacts at concentrations of 1250 ppm and above, including anemia, liver damage, and changes in clinical pathology.
|
2008 |
AR226-3818
|
ByZQVb83dD2onV2b511QMjaRk |
2 |
|
The document provides updated occupational serum sampling results for PFOA levels in workers at the DuPont Chambers Works site in New Jersey for December 2007, indicating levels that are generally consistent with previously reported findings.
|
2008 |
AR226-3817
|
zZr0Km7KnN4dqpzymQrpp07m |
12 |
|
This document is a submission from 3M to the EPA providing monitoring data on perfluorooctanoic acid (PFOA) from groundwater, wastewater, fish, clams, and sediment samples collected near their manufacturing facility in Decatur, Alabama, fulfilling commitments under previous Letters of Intent.
|
2008 |
AR226-3819
|
pJdkobG55m0d9E5VRXGxxjr7 |
5 |
|
The document discusses the submission of a Letter of Intent (LOI) by 3M to the EPA regarding PFOA, and the coordination among EPA staff to ensure that corrected pages are submitted and processed appropriately.
|
2008 |
AR226-3820
|
0619pYQwNo4a8mQaqdaogXnEJ |
8 |
|
3M is submitting a TSCA 8(e) Substantial Risk Notice to the U.S. EPA to supplement its previous submissions regarding sulfonate-based and carboxylate-based fluorochemicals, including PFOA and PFOS.
|
2008 |
AR226-3821
|
mB37e5RKmyonYzBV433p3rd1k |
1 |
|
3M notified the EPA of a completed five-day repeat dose oral toxicity study on a fluorinated surfactant salt, which resulted in the death of all six female rats treated with 288 mg/kg/day, while no male rats in the same dose group died.
|
2008 |
AR226-3823
|
zq5vnjqaDa600gmNKbyQakKm |
1 |
|
The document discusses 3M's assertion of confidential business information (CBI) regarding a substance related to PFOA/PFOS, outlining the indefinite period for confidentiality and the company's security measures to protect this information.
|
2008 |
AR226-3824
|
Bv3yRYJgYzGJ8baDkO4gkDVBE |
4 |
|
This document is a submission to the TSCA 8(e)/FYI Database by Robert A. Bilott, providing information regarding PFOA/PFOS, including C-8 Science Panel Status Reports and a study on health effects among community residents exposed to perfluorooctanoate.
|
2008 |
AR226-3825
|
jyZGY4L7pbpDdLp33Q1DNKNyN |
1 |
|
The document outlines the C8 Science Panel's submission of three status reports to the Wood County Court regarding health studies on PFOA and PFOS exposure in a community near a chemical plant, focusing on factors associated with PFOA levels, lipid associations, and Type II diabetes.
|
2008 |
AR226-3826
|
93vrq85KN99De7rQ7yVb6Yp17 |
14 |
|
The document is a submission from 3M to the EPA regarding an environmental assessment of perfluoroalkyl sulfonates, including PFOS, PFHS, and PFBS, conducted at the 3M Decatur, Alabama manufacturing site, as part of a voluntary monitoring program following a Memorandum of Understanding with the EPA.
|
2008 |
AR226-3828
|
kkeerm3yn1QDRJ248Z9vkK9E |
2 |
|
This study evaluates self-reported health effects among residents exposed to perfluorooctanoate (PFOA) in their drinking water, finding a statistically significant increased prevalence of serious health issues such as angina, myocardial infarction, and stroke, suggesting a potential link to PFOA exposure.
|
2008 |
AR226-3827
|
gD60w4Lnqypq58gX3E52Ym049 |
15 |
|
This document is a submission to the TSCA 8(e)/FYI Database by Taft Stettinius & Hollister LLP, providing information regarding PFOA/PFOS, including status reports from the C-8 Science Panel and a study on health effects among residents exposed to perfluorooctanoate.
|
2008 |
AR226-3834
|
zQ0ymQM4qkn4wVG5JooKadgQ7 |
1 |
|
The document outlines the C8 Science Panel's submission of three status reports to the Wood County Court regarding health effects associated with PFOA exposure in a community near a chemical plant, including findings on PFOA levels, lipid associations, and Type II diabetes.
|
2008 |
AR226-3835
|
zVYrjvkNoV4nozXxjVERGyg3 |
14 |
|
This study evaluates self-reported health effects among residents exposed to perfluorooctanoate (PFOA) in their drinking water, finding statistically significant higher prevalence rates of serious health issues such as angina, myocardial infarction, and stroke, suggesting a potential link to PFOA exposure.
|
2008 |
AR226-3836
|
rp7ddw163ak6K7yvzx5rRgvEa |
15 |
|
The document reports occupational PFOA sampling results for workers at DuPont's Shimizu Facility in Japan, indicating levels of PFOA in blood plasma samples, with an average concentration of 2551 ppb and a maximum of 8370 ppb, which are consistent with previously reported levels in similar occupational settings.
|
2008 |
AR226-3837
|
keEGGkOpO1Jo5ZNvbVq50NED |
3 |
|
DuPont submitted water sample results for PFOA from various public water districts in New Jersey to the EPA in response to an OPRA request, while noting that they do not verify the accuracy of the third-party documents enclosed.
|
2008 |
AR226-3838
|
XR7jVwj6dBNYGJadZngae0j2K |
4 |
|
This analytical report details the testing of water samples for perfluorooctanoic acid (PFOA) and perfluorooctanesulfonate (PFOS) by TestAmerica Denver, confirming compliance with laboratory quality standards and providing quantitation methods for both substances.
|
2008 |
AR226-3845
|
pppMDdBO0jej1204LQ0NMwgdj |
23 |
|
This analytical report from TestAmerica Denver details the testing of a water sample for perfluorooctanoic acid (PFOA) and perfluorooctanesulfonate (PFOS), confirming compliance with laboratory quality standards and providing analytical results for the detected substances.
|
2008 |
AR226-3846
|
0qGMyJeVJYGBoNZJjV15RZExR |
19 |
|
This analytical report from TestAmerica details the testing of a water sample for perfluorooctanoic acid (PFOA) and perfluorooctanesulfonate (PFOS), confirming compliance with laboratory quality standards and outlining the methods used for extraction and quantitation.
|
2008 |
AR226-3847
|
X7z6bXyRO9wwwRZwZVMDD22a4 |
14 |
|
This document is a forwarded email from Laura Vancho to Betty Boros-Russo, containing a PFOA/PFOS report and electronic data deliverable (EDD) for samples collected on March 17, 2008, with the lot number D8C180234, prepared by TestAmerica.
|
2008 |
AR226-3852
|
wgD14rQV6nEEJ1jRpOYRz3JXD |
15 |
|
This analytical report from TestAmerica details the testing of nine water samples for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), confirming compliance with laboratory quality standards and providing results for the samples received on March 18, 2008.
|
2008 |
AR226-3853
|
b1rGdKJGBnB5jYe2oBYn3mD6 |
27 |
|
The document discusses the delivery of analytical files related to water samples from a well (D7F290273) and includes a .csv file containing data, but does not provide PDF files for the remaining samples.
|
2008 |
AR226-3855
|
EdkYr1mjD7x0QqK47K03Ky3an |
18 |
|
This analytical report from TestAmerica Denver details the compliance and results of PFOA and PFOS analyses conducted on three samples received on December 14, 2007, confirming that all data met laboratory QA/QC protocols.
|
2008 |
AR226-3856
|
06Y88qMQ4vXG16Bm8Rzqvakwm |
20 |
|
The document is a cover letter from the Sayreville Water Department to the New Jersey Department of Environmental Protection, enclosing PFOA sampling results and indicating compliance with laboratory quality standards.
|
2008 |
AR226-3858
|
50y1Me1YkazrERZ5X2Mpy2bDN |
20 |
|
The document reports the results of PFOA and PFOS sampling conducted by the Sayreville Water Department, indicating detected levels of 0.0075 µg/L for PFOA and 0.0042 µg/L for PFOS at the Bedminster Plant, and 0.0070 µg/L for PFOA and 0.0034 µg/L for PF
|
2008 |
AR226-3859
|
OEm0JmB4Obpr7b12L9mzMdJ8j |
5 |
|
The document contains the PFOA/PFOS analytical results for the City of Salem's third round of samples collected in the first quarter of 2008, as communicated by Fred Mucci and provided by QC Laboratories.
|
2008 |
AR226-3862
|
v60ejV6QQGqe8j4JGe8vZ50Rw |
22 |
|
The document discusses the results of the fourth round of PFOA/PFOS sampling conducted in the City of Salem for the second quarter of 2008, and includes a request for guidance on whether to continue sampling for these substances.
|
2008 |
AR226-3863
|
MM27EmyZwGOw3gyr2Ew9Vrrnz |
19 |
|
The document discusses a study examining the association between serum perfluoroalkyl chemicals, including PFOA and PFOS, and glucose homeostasis and metabolic syndrome in adolescents and adults.
|
2008 |
AR226-3874
|
Lpk1nMX9wRGbnYqNRbN6KpgD3 |
13 |
|
This document is a TSCA Section 8(e) Substantial Risk Notice from 3M regarding the development of a testing method for determining whether fluoropolymers can generate perfluorooctanoic acid (PFOA) when heated, submitted to the EPA as part of ongoing assessments of fluorochemical exposure pathways.
|
2008 |
AR226-3939
|
wrObn94o2yBgB2z7V1vKEawG3 |
39 |
|
The document is an interim report detailing the analysis of Perfluorobutanesulfonate (PFBS), Perfluorohexanesulfonate (PFHS), and Perfluorooctanesulfonate (PFOS) in surface water and sediment samples as part of the 3M Decatur Monitoring Program, conducted by MPI Research, Inc. under EPA TSCA Good Laboratory
|
2008 |
AR226-3828
|
jmLjR2dqe4BDz13DOVVej1p6R |
107 |
|
This interim report details the analysis of Perfluorobutanesulfonate (PFBS), Perfluorohexanesulfonate (PFHS), and Perfluorooctanesulfonate (PFOS) in various environmental samples as part of the 3M Decatur Monitoring Program, conducted by MPI Research, Inc. in compliance with EPA TSCA Good Laboratory Practice Standards.
|
2008 |
AR226-3828
|
EdrzqJ0EBoMeB1Q8KZg76ovnR |
197 |
|
The document is an interim report detailing the analysis of Perfluorobutane sulfonate (PFBS), Perfluorohexanesulfonate (PFHS), and Perfluorooctane sulfonate (PFOS) in various environmental samples from the 3M Decatur Monitoring Program, conducted in compliance with EPA TSCA Good Laboratory Practice Standards.
|
2008 |
AR226-3828
|
zoejgQKv3wxjemEe6kX8Vq1Dz |
135 |
|
The document is an analytical report prepared by Severn Trent Laboratories for Weston Solutions, Inc. regarding a confidential investigation into water samples collected on January 26, 2005, as part of the Decatur - FC investigation, but does not specify findings related to PFOA or PFOS.
|
2008 |
AR226-3828
|
ypOK1g3bayjkJRbY1ZYq1knYn |
36 |
|
The document is a final report from the 3M Environmental Laboratory detailing the analysis of perfluorinated compounds, including PFOA and PFOS, in aqueous samples collected from the 3M Decatur facility for quarterly monitoring under NPDES Permit Number AL0000205.
|
2008 |
AR226-3828
|
gEvGxvpLORmRLpO8gZB8wRk5e |
13 |
|
The document is a final report from the 3M Environmental Laboratory detailing the analysis of PFBA, PFOA, PFBS, PFOS, FBSA, and FOSA in aqueous samples collected from 3M's Decatur, Alabama facility as part of their NPDES permit monitoring for the second quarter of 2008.
|
2008 |
AR226-3828
|
p180dBzBo8Mog73YYY5wXZ87 |
12 |
|
The document is a final laboratory report from 3M Environmental Laboratory detailing the analysis of PFBA, PFOA, PFBS, PFOS, FBSA, and FOSA in aqueous samples collected from the 3M Decatur facility for quarterly monitoring under NPDES Permit Number AL0000205.
|
2008 |
AR226-3828
|
Nw4XbQBKNgME4KebjNdQ8DOD |
12 |
|
This document is a data report prepared by Weston Solutions, Inc. for 3M Company and Dyneon, LLC, detailing the environmental monitoring program related to perfluorinated sulfonates at the 3M Decatur, Alabama facility as of September 2008.
|
2008 |
AR226-3828
|
99XwEKL5xrmroE7VyY3GXL6Np |
407 |
|
This interim report details the analysis of Perfluorobutanesulfonate (PFBS), Perfluorohexanesulfonate (PFHS), and Perfluorooctanesulfonate (PFOS) in various environmental samples as part of the 3M Decatur Monitoring Program, conducted by MPI Research, Inc. in compliance with EPA TSCA Good Laboratory Practice Standards.
|
2008 |
AR226-3828
|
DZv9vGY8rvjbpL2vYymbgozM |
149 |
|
This document is a correspondence from DuPont Chemical Solutions Enterprise detailing additional information on studies related to the global fate and exposure potential of DuPont's fluorotelomer products and their biodegradation, following a meeting with the EPA.
|
2007 |
AR226-3753
|
gbp3YY9Ve2Eoeog6zVmRxdeaG |
28 |
|
3M submitted a corrected copy of their Final Report on the effects of perfluorinated alkyl sulfonates, including perfluorooctane sulfonate and perfluorooctanoic acid, on cholesterol and bile acid metabolism in mice and fatty acid conversion in rat hepatocytes, indicating the study is not confidential.
|
2007 |
AR226-3757
|
5Dk2jmrMD66ypJoJRNeOpw104 |
4 |
|
3M submitted additional data on perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA), including several environmental toxicity study reports, to the EPA's Document Control Office.
|
2007 |
AR226-3769
|
KJry5VRXzkpBN3v5XDbVomw9r |
1 |